FRTX logo

FRTX Return On Equity

FRTX Annual ROE

-66.50%
+64.97%+49.42%

31 December 2023

FRTX ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

FRTX Quarterly ROE

-58.80%
+36.31%+38.18%

31 December 2023

FRTX Quarterly ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

FRTX ROE Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+49.4%+38.2%
3 y3 years+44.8%+38.2%
5 y5 years-129.8%+38.2%

FRTX ROE High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+56.2%at high+66.8%
5 y5-yearat high+56.2%at high+66.8%
alltimeall time-953.9%+56.2%-1668.0%+77.0%

Fresh Tracks Therapeutics ROE History

DateAnnualQuarterly
Dec 2023
-66.50%(-49.4%)
-58.80%(-38.2%)
Sept 2023
-
-95.11%(-42.3%)
June 2023
-
-164.75%(+23.7%)
Mar 2023
-
-133.14%(-5.3%)
Dec 2022
-131.47%(-13.3%)
-140.66%(+9.1%)
Sept 2022
-
-128.97%(-14.6%)
June 2022
-
-151.03%(-14.9%)
Mar 2022
-
-177.37%(+11.0%)
Dec 2021
-151.70%(+25.9%)
-
Dec 2021
-
-159.80%(-8.0%)
Sept 2021
-
-173.78%(+28.0%)
June 2021
-
-135.79%(+6.0%)
Mar 2021
-
-128.06%(-3.0%)
Dec 2020
-120.50%(+42.2%)
-131.98%(-24.0%)
Sept 2020
-
-173.58%(+30.1%)
June 2020
-
-133.47%(+41.0%)
Mar 2020
-
-94.64%(+33.7%)
Dec 2019
-84.76%(+192.9%)
-70.78%(+88.1%)
Sept 2019
-
-37.63%(+48.9%)
June 2019
-
-25.27%(-11.0%)
Mar 2019
-
-28.38%(-3.5%)
Dec 2018
-28.94%(+21.4%)
-29.42%(-4.7%)
Sept 2018
-
-30.88%(-13.0%)
June 2018
-
-35.49%(+4.7%)
Mar 2018
-
-33.91%(+19.7%)
Dec 2017
-23.84%(+20.3%)
-28.32%(+0.6%)
Sept 2017
-
-28.16%(+7.2%)
June 2017
-
-26.26%(+24.0%)
Mar 2017
-
-21.17%(+5.8%)
Dec 2016
-19.82%(+4.4%)
-20.01%(+5.9%)
Sept 2016
-
-18.89%(+34.7%)
June 2016
-
-14.02%(-16.7%)
Mar 2016
-
-16.83%(-12.0%)
Dec 2015
-18.99%(-34.7%)
-19.13%(-16.4%)
Sept 2015
-
-22.87%(-23.4%)
June 2015
-
-29.84%(-3.5%)
Mar 2015
-
-30.93%(+6.7%)
Dec 2014
-29.10%(-29.9%)
-28.99%(+21.9%)
Sept 2014
-
-23.78%(-24.3%)
June 2014
-
-31.41%(-16.9%)
Mar 2014
-
-37.82%(-11.3%)
Dec 2013
-41.51%(+35.4%)
-42.64%(-6.6%)
Sept 2013
-
-45.64%(+16.8%)
June 2013
-
-39.06%(+15.4%)
Mar 2013
-
-33.86%(+35.4%)
Dec 2012
-30.65%(+162.4%)
-25.00%(-0.9%)
Sept 2012
-
-25.22%(-994.3%)
June 2012
-
2.82%(+16.5%)
Mar 2012
-
2.42%(-119.7%)
Dec 2011
-11.68%(-77.1%)
-12.28%(+1.2%)
Sept 2011
-
-12.14%(-77.5%)
June 2011
-
-54.00%(+1.2%)
Mar 2011
-
-53.37%(+0.2%)
Dec 2010
-50.92%(-7.6%)
-53.25%(-4.0%)
Sept 2010
-
-55.48%(-6.2%)
June 2010
-
-59.14%(+6.8%)
Mar 2010
-
-55.39%(-0.5%)
Dec 2009
-55.13%(-4.0%)
-55.68%(-5.0%)
Sept 2009
-
-58.61%(-5.6%)
June 2009
-
-62.06%(-1.2%)
Mar 2009
-
-62.84%(+9.8%)
Dec 2008
-57.41%(+55.2%)
-57.25%(+12.8%)
Sept 2008
-
-50.75%(+13.0%)
June 2008
-
-44.92%(+10.4%)
Mar 2008
-
-40.68%(+9.8%)
Dec 2007
-37.00%
-37.05%(+3.5%)
Sept 2007
-
-35.79%(+3.6%)
DateAnnualQuarterly
June 2007
-
-34.55%(+12.4%)
Mar 2007
-
-30.73%(+15.6%)
Dec 2006
-23.81%(-20.2%)
-26.58%(-1.8%)
Sept 2006
-
-27.06%(+3.4%)
June 2006
-
-26.17%(-9.5%)
Mar 2006
-
-28.92%(-11.2%)
Dec 2005
-29.85%(+8.6%)
-32.57%(+7.2%)
Sept 2005
-
-30.38%(+13.6%)
June 2005
-
-26.75%(+5.2%)
Mar 2005
-
-25.42%(-3.2%)
Dec 2004
-27.48%(+14.7%)
-26.27%(-6.6%)
Sept 2004
-
-28.12%(+8.2%)
June 2004
-
-26.00%(-3.3%)
Mar 2004
-
-26.89%(+11.9%)
Dec 2003
-23.96%(+10.0%)
-24.04%(+4.1%)
Sept 2003
-
-23.10%(-16.0%)
June 2003
-
-27.49%(+13.0%)
Mar 2003
-
-24.32%(+12.6%)
Dec 2002
-21.78%(+245.2%)
-21.60%(+33.4%)
Sept 2002
-
-16.19%(+59.4%)
June 2002
-
-10.16%(+16.8%)
Mar 2002
-
-8.70%(+37.9%)
Dec 2001
-6.31%(-29.8%)
-6.31%(-16.9%)
Sept 2001
-
-7.59%(+9.8%)
June 2001
-
-6.91%(+35.5%)
Mar 2001
-
-5.10%(-23.7%)
Dec 2000
-8.99%(-48.2%)
-6.68%(+32.5%)
Sept 2000
-
-5.04%(-34.1%)
June 2000
-
-7.65%(-45.9%)
Mar 2000
-
-14.14%(-16.1%)
Dec 1999
-17.36%(+1.8%)
-16.85%(-20.0%)
Sept 1999
-
-21.06%(+15.8%)
June 1999
-
-18.19%(+5.1%)
Mar 1999
-
-17.30%(+2.4%)
Dec 1998
-17.05%(+45.5%)
-16.89%(+17.2%)
Sept 1998
-
-14.41%(+33.5%)
June 1998
-
-10.79%(+14.9%)
Mar 1998
-
-9.39%(-22.7%)
Dec 1997
-11.72%(+16.8%)
-12.14%(-4.1%)
Sept 1997
-
-12.66%(-21.9%)
June 1997
-
-16.22%(+57.3%)
Mar 1997
-
-10.31%(+4.9%)
Dec 1996
-10.03%(+1.8%)
-9.83%(+2.4%)
Sept 1996
-
-9.60%(+14.0%)
June 1996
-
-8.42%(-11.1%)
Mar 1996
-
-9.47%(-4.6%)
Dec 1995
-9.85%(-32.5%)
-9.93%(-26.8%)
Sept 1995
-
-13.56%(-10.3%)
June 1995
-
-15.12%(-4.3%)
Mar 1995
-
-15.80%(+8.7%)
Dec 1994
-14.59%(+113.0%)
-14.53%(+30.3%)
Sept 1994
-
-11.15%(-16.1%)
June 1994
-
-13.29%(-23.3%)
Mar 1994
-
-17.32%(+161.6%)
Dec 1993
-6.85%(-83.9%)
-6.62%(-1.5%)
Sept 1993
-
-6.72%(+38.6%)
June 1993
-
-4.85%(-229.3%)
Mar 1993
-
3.75%(-107.9%)
Dec 1992
-42.55%(-62.1%)
-47.62%(-77.4%)
Sept 1992
-
-211.11%(-5.0%)
June 1992
-
-222.22%(-9.1%)
Mar 1992
-
-244.44%(-4.4%)
Dec 1991
-112.20%(+111.2%)
-255.56%(+271.7%)
Sept 1991
-
-68.75%(+10.0%)
June 1991
-
-62.50%(+11.1%)
Mar 1991
-
-56.25%(+5.9%)
Dec 1990
-53.13%
-53.13%

FAQ

  • What is Fresh Tracks Therapeutics annual return on equity?
  • What is the all time high annual ROE for Fresh Tracks Therapeutics?
  • What is Fresh Tracks Therapeutics annual ROE year-on-year change?
  • What is Fresh Tracks Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Fresh Tracks Therapeutics?
  • What is Fresh Tracks Therapeutics quarterly ROE year-on-year change?

What is Fresh Tracks Therapeutics annual return on equity?

The current annual ROE of FRTX is -66.50%

What is the all time high annual ROE for Fresh Tracks Therapeutics?

Fresh Tracks Therapeutics all-time high annual return on equity is -6.31%

What is Fresh Tracks Therapeutics annual ROE year-on-year change?

Over the past year, FRTX annual return on equity has changed by +64.97% (+49.42%)

What is Fresh Tracks Therapeutics quarterly return on equity?

The current quarterly ROE of FRTX is -58.80%

What is the all time high quarterly ROE for Fresh Tracks Therapeutics?

Fresh Tracks Therapeutics all-time high quarterly return on equity is 3.75%

What is Fresh Tracks Therapeutics quarterly ROE year-on-year change?

Over the past year, FRTX quarterly return on equity has changed by +36.31% (+38.18%)